The simultaneous overexpression of MYC, SP1, RUNX1 and GATA2 would enhance the transcription of SET, which would trigger PP2A inactivation in AML, contributing to the leukemogenic phenotype. This evidence concerns the gene SET and acute myeloid leukemia.